Fred Moll
InvestorManaging Partner at Sonder Capital · Board director at Cephea Valve Technologies · Board director at Qool Therapeutics · Board director at PROCEPT BioRobotics Corp
Mountain View, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Fred
67 people in our graph share verified history with Fred — schools, employers, funds. One of them is your warm intro.
About
Fred Moll is a medtech entrepreneur with over 40 years of experience in robotic surgery. He co-founded and served as CEO of Intuitive Surgical, developer of the da Vinci surgical system, and later founded and led Auris Health, whose Monarch platform was acquired by Johnson & Johnson in 2019. He holds a B.A. in Economics from UC Berkeley, an M.S. in Management from Stanford, and an M.D. from the University of Washington.
Contact· self-published, not guessed
Invests in
Medical DevicesRobotics
Board director at Cephea Valve Technologies
Intro paths
In turn, Fred can intro founders to Cephea Valve Technologies's investors below.
Cephea Valve Technologies's investors · 1
Board director at Qool Therapeutics
Intro paths
In turn, Fred can intro founders to Qool Therapeutics's investors below.
Qool Therapeutics's investors · 3
Co-founders at Qool Therapeutics
Board director at PROCEPT BioRobotics Corp
Intro paths
In turn, Fred can intro founders to PROCEPT BioRobotics Corp's investors below.
PROCEPT BioRobotics Corp's investors · 2
Co-founders at PROCEPT BioRobotics Corp
Experience
- Johnson & Johnson Medical DevicesChief Development Officer - Roboticscurrent2019 — present
- Johnson & Johnson Medical DevicesChief Development Officercurrent2019 — present
- Auris RoboticsChairman of the Board and CEO2013 — 2019
Deals · 3
ReflexionmedicalBoard seat
via Sonder Capital · filed Apr 2018 · $102.6M raise
Qool TherapeuticsBoard seat
via Sonder Capital · filed Nov 2015 · $1M raise
PROCEPT BioRobotics CorpBoard seat
via Sonder Capital · filed Jul 2015 · $7.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
InsightecMomentis SurgicalMoon SurgicalNeptune MedicalProcept BioRobotics, Inc.SS Innovations InternationalVitestro
Investor
AlifeBright UroForSight RoboticsG.I. WindowsHalo DiagnosticsHansen MedicalHeruHistoSonicsMendaeraMoon SurgicalNaya HealthNeocisNeuro42Petal SurgicalPrimaNova LabProclaimPromaxoTympaHealthVitestroXCath
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Sonder Capital
Network10
Investors connected to Fred in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Fred Moll?
- Fred Moll is a medtech entrepreneur with over 40 years of experience in robotic surgery. He co-founded and served as CEO of Intuitive Surgical, developer of the da Vinci surgical system, and later founded and led Auris Health, whose Monarch platform was acquired by Johnson & Johnson in 2019. He holds a B.A. in Economics from UC Berkeley, an M.S. in Management from Stanford, and an M.D. from the University of Washington.
- Where does Fred Moll work?
- Fred Moll is Managing Partner at Sonder Capital and Board director at Cephea Valve Technologies and Board director at Qool Therapeutics and Board director at PROCEPT BioRobotics Corp.
- What does Fred Moll invest in?
- Fred Moll invests in Medical Devices, Robotics.
- What check size does Fred Moll write?
- Fred Moll typically writes checks of $100K – $5M.
- What boards does Fred Moll sit on?
- Fred Moll holds tracked board seats at Insightec, Momentis Surgical, Moon Surgical, Neptune Medical, PROCEPT BioRobotics Corp, Procept BioRobotics, Inc., Qool Therapeutics, Reflexionmedical, SS Innovations International, Vitestro.
- What companies has Fred Moll invested in?
- Investments tracked here include Alife, Bright Uro, ForSight Robotics, G.I. Windows, Halo Diagnostics, Hansen Medical, Heru, HistoSonics, Mendaera, Moon Surgical, Naya Health, Neocis, and 8 more.
Shared employers
Also worked at Johnson & Johnson Medical Devices66
+ 60 more